LifeSci Communications Fierce Pharma Asia—Takeda's Anima mRNA translation pact, China digital health incubator; Daiichi's COVID-19 vaccine

Takeda penned a potentially billion-dollar deal with Anima Biotech to work on mRNA translation modulators for neurological diseases. The Japanese pharma als

Anima Biotech - Company info. interviews, news

Japan's Daiichi Sankyo to seek OK for omicron booster by April 2024 - Nikkei Asia

Anima Biotech - mRNA Lightning Platform

Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine

Anima Biotech - mRNA Lightning Platform

Takeda bags mRNA translation modulators in $120M Anima deal

Sponsor Detail Template – Chinese American Biopharmaceutical Society

Sponsor Detail Template – Chinese American Biopharmaceutical Society

LifeSci Communications Fierce Pharma Asia—Takeda's Anima mRNA translation pact, China digital health incubator; Daiichi's COVID-19 vaccine

JCI - Article_in_issue

Daiichi Sankyo to establish Japan's first mRNA production facility

COVID-19 tracker: Pfizer, Moderna vaccines sharply cut hospitalizations in older adults, CDC data show

Chinese COVID-19 vaccine Ad5-Ncov shows high antibody levels at Russian trial -Ifax

JCI - Article_in_issue